Literature DB >> 16087358

Steroids in intractable childhood epilepsy: clinical experience and review of the literature.

Helene Verhelst1, Paul Boon, Gunnar Buyse, Berten Ceulemans, Marc D'Hooghe, Linda De Meirleir, Danièle Hasaerts, An Jansen, Lieven Lagae, Alfred Meurs, Rudy Van Coster, Kristl Vonck.   

Abstract

Steroids and adrenocorticotrophic hormone (ACTH) have been used for the treatment of infantile spasms for several years. However, the use of steroids in the treatment of epilepsy beyond infantile spasms has been limited to only a few studies. We report the experience with steroids in 32 children with intractable epilepsy, not including West syndrome. In 47% there was a decrease in seizure frequency, 25% became seizure free, 11% had a seizure reduction of >50% and 11% had a seizure reduction of <50%. Our study confirms the conclusions of few previous reports of effective adjunctive steroid treatment for children with intractable epilepsy. The possible side effects, however, especially during prolonged therapy remain an important concern.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16087358     DOI: 10.1016/j.seizure.2005.07.002

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  23 in total

1.  The blood-brain barrier hypothesis in drug resistant epilepsy.

Authors:  Nicola Marchi; Tiziana Granata; Andreas Alexopoulos; Damir Janigro
Journal:  Brain       Date:  2012-01-16       Impact factor: 13.501

Review 2.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

3.  Population-level evidence for an autoimmune etiology of epilepsy.

Authors:  Mei-Sing Ong; Isaac S Kohane; Tianxi Cai; Mark P Gorman; Kenneth D Mandl
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

4.  Intravenous methylprednisolone pulse therapy for children with epileptic encephalopathy.

Authors:  Maria Carmela Pera; Giovanna Randazzo; Silvia Masnada; Serena Donetti Dontin; Valentina De Giorgis; Umberto Balottin; Pierangelo Veggiotti
Journal:  Funct Neurol       Date:  2015 Jul-Sep

Review 5.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 6.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

Review 7.  Management of the patient with medically refractory epilepsy.

Authors:  Tiziana Granata; Nicola Marchi; Erin Carlton; Chaitali Ghosh; Jorge Gonzalez-Martinez; Andreas V Alexopoulos; Damir Janigro
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

Review 8.  Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches.

Authors:  Nicola Marchi; Tiziana Granata; Chaitali Ghosh; Damir Janigro
Journal:  Epilepsia       Date:  2012-08-20       Impact factor: 5.864

Review 9.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

10.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.